Recent Updates
Recently added Catalysts
RVTY

PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2020 4Q Revenue of $1.355 billion; 68% reported growth; 65% organic growth 4Q GAAP EPS from continuing operations of $3.38; Adjusted EPS of

Key Takeaway: PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2020 4Q Revenue of $1.355 billion; 68% reported growth; 65% organic growth 4Q GAAP EPS from continuing operations of $3.38; Adjusted EPS of $3.96 Initiates First Quarter and Full Year 2021 Guidance

Full Press Release Details

PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2020

4Q Revenue of $1.355 billion; 68% reported growth; 65% organic growth
4Q GAAP EPS from continuing operations of $3.38; Adjusted EPS of $3.96
Initiates First Quarter and Full Year 2021 Guidance
WALTHAM, Mass.--(BUSINESS WIRE)--February 2, 2021--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the fourth quarter and full year ended January 3, 2021.
The Company reported GAAP earnings per share from continuing operations of $3.38, as compared to GAAP earnings per share from continuing operations of $0.58 in the fourth quarter of 2019. GAAP revenue for the quarter was $1.355 billion, as
compared to $805 million in the fourth quarter of 2019. GAAP operating income from continuing operations for the quarter was $510 million, as compared to $138 million for the same period a year ago. GAAP operating profit margin was 37.7% as a
percentage of revenue, as compared to 17.2% in the fourth quarter of 2019.
Adjusted earnings per share from continuing operations for the quarter was $3.96, as compared to $1.35 in the fourth quarter of 2019. Adjusted revenue for the quarter was $1.355 billion, as compared to $806 million in the fourth quarter of
2019. Adjusted operating income from continuing operations for the quarter was $571 million, as compared to $192 million for the same period a year ago. Adjusted operating profit margin was 42.2% as a percentage of adjusted revenue, as compared
to 23.9% in the fourth quarter of 2019.
The Company reported GAAP earnings per share from continuing operations of $6.50, as compared to GAAP earnings per share from continuing operations of $2.04 in 2019. GAAP revenue for the year was $3.783 billion, as compared to $2.884 billion
in 2019. GAAP operating income from continuing operations for the year was $979 million, as compared to $362 million in 2019. GAAP operating profit margin was 25.9% as a percentage of revenue, as compared to 12.6% in 2019.
Adjusted earnings per share from continuing operations for the year was $8.30, as compared to $4.10 in 2019. Adjusted revenue for the year was $3.784 billion, as compared to $2.884 billion in 2019. Adjusted operating income from continuing
operations for the year was $1.203 billion, as compared to $596 million in 2019. Adjusted operating profit margin was 31.8% as a percentage of adjusted revenue, as compared to 20.7% in 2019.
Adjustments for the Company's non-GAAP financial measures have been noted in the attached reconciliations.
"While the fourth quarter and full year financial results are certainly impressive, we have many accomplishments beyond the headline financial numbers to be proud of," said Prahlad Singh, president and chief executive officer of PerkinElmer.
"The team's response to the pandemic, and their resolute focus throughout 2020 to be a part of the solution, was humbling and inspiring to watch. As we look ahead, I could not be more excited about the future for PerkinElmer."
Financial Overview by Reporting Segment for the Fourth Quarter and Full Year 2020
Discovery & Analytical Solutions
Fourth quarter 2020 revenue was $503 million, as compared to $496 million for the fourth quarter of 2019. Reported revenue increased 1% and organic revenue decreased 2% as compared to the fourth quarter of 2019. Full year 2020 revenue was
$1.716 billion, as compared to $1.746 billion in 2019. Full year reported revenue decreased 2% and organic revenue decreased 4%.
Fourth quarter 2020 operating income from continuing operations was $73 million, as compared to $91 million for the comparable prior period. Full year 2020 operating income was $183 million, as compared to $238 million in 2019.
Fourth quarter 2020 adjusted operating income was $92 million, as compared to $116 million for the fourth quarter of 2019. Full year 2020 adjusted operating income was $267 million, as compared to $338 million in 2019.
Fourth quarter 2020 revenue was $852 million, as compared to $309 million for the fourth quarter of 2019. Reported revenue increased 176% and organic revenue increased 172% as compared to the fourth quarter of 2019. Full year 2020 revenue
was $2.067 billion, as compared to $1.138 billion in 2019. Full year reported revenue increased 82% and organic revenue increased 81%.
Fourth quarter 2020 operating income from continuing operations was $460 million, as compared to $61 million for the comparable prior period. Full year 2020 operating income was $874 million, as compared to $189 million in 2019.
Fourth quarter 2020 adjusted operating income was $502 million, as compared to $91 million for the fourth quarter of 2019. Full year 2020 adjusted operating income was $1.010 billion, as compared to $316 million in 2019.
Initiates Financial Guidance: First Quarter and Full Year 2021 Guidance
For the first quarter of 2021, the Company forecasts GAAP revenue of approximately $1.19 billion. GAAP earnings per share from continuing operations of at least $2.52 and, on a non-GAAP basis, which is expected to include the adjustments
noted in the attached reconciliation, adjusted earnings per share of at least $3.00.
For the full year of 2021, the Company forecasts GAAP revenue of at least $4.08 billion. GAAP earnings per share from continuing operations of at least $6.73 and, on a non-GAAP basis, which is expected to include the adjustments noted
in the attached reconciliation, adjusted earnings per share of at least $8.50.
Conference Call Information
The Company will discuss its fourth quarter and full year 2020 results and its outlook for business trends in a conference call on February 2, 2021 at 5:00 p.m. Eastern Time. To access the call, please dial (720) 405-2250 prior to the
scheduled conference call time and provide the access code 2779705.
A live audio webcast of the call will be available on the Investors section of the Company's Web site, www.perkinelmer.com. Please go to the site at least 15 minutes prior to the call in order to register, download, and install any necessary
software. An archived version of the webcast will be posted on the Company's Web site for a two-week period beginning approximately two hours after the call.
Use of Non-GAAP Financial Measures
In addition to financial measures prepared in accordance with generally accepted accounting principles (GAAP), this earnings announcement also contains non-GAAP financial measures. The reasons that we use these measures, a reconciliation of
these measures to the most directly comparable GAAP measures, and other information relating to these measures are included below following our GAAP financial statements.
Factors Affecting Future Performance
This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share,
cash flow and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities, acquisitions and divestitures. Words such as "believes," "intends,"
"anticipates," "plans," "expects," "projects," "forecasts," "will" and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management's current assumptions and
expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in
any forward-looking statements. These factors include, without limitation: (1) markets into which we sell our products declining or not growing as anticipated; (2) the effect of the COVID-19 pandemic on our sales and operations; (3)
fluctuations in the global economic and political environments; (4) our failure to introduce new products in a timely manner; (5) our ability to execute acquisitions and license technologies, or to successfully integrate acquired businesses and
licensed technologies into our existing business or to make them profitable, or successfully divest businesses; (6) our failure to adequately protect our intellectual property; (7) the loss of any of our licenses or licensed rights; (8) our
ability to compete effectively; (9) fluctuation in our quarterly operating results and our ability to adjust our operations to address unexpected changes; (10) significant disruption in third-party package delivery and import/export services or
significant increases in prices for those services; (11) disruptions in the supply of raw materials and supplies; (12) the manufacture and sale of products exposing us to product liability claims; (13) our failure to maintain compliance with
applicable government regulations; (14) regulatory changes; (15) our failure to comply with healthcare industry regulations; (16) economic, political and other risks associated with foreign operations; (17) our ability to retain key personnel;
(18) significant disruption in our information technology systems, or cybercrime; (19) our ability to obtain future financing; (20) restrictions in our credit agreements; (21) discontinuation or replacement of LIBOR; (22) the United Kingdom's
withdrawal from the European Union; (23) our ability to realize the full value of our intangible assets; (24) significant fluctuations in our stock price; (25) reduction or elimination of dividends on our common stock; and (26) other factors
which we describe under the caption "Risk Factors" in our most recent quarterly report on Form 10-Q and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking
statements as a result of developments occurring after the date of this press release.
PerkinElmer, Inc. is a global leader focused on innovating for a healthier world. The Company reported revenue of approximately $3.8 billion in 2020, has about 14,000 employees serving customers in more than 190 countries, and is a component
of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.
PerkinElmer, Inc. and Subsidiaries
CONDENSED CONSOLIDATED INCOME STATEMENTS
Three Months Ended Twelve Months Ended
(In thousands, except per share data) January 3, 2021 December 29, 2019 January 3, 2021 December 29, 2019
Revenue $ 1,354,606 $ 805,496 $ 3,782,745 $ 2,883,673
Cost of revenue 527,541 407,315 1,672,868 1,487,618
Selling, general and administrative expenses 263,050 210,737 917,894 815,318
Research and development expenses 56,823 47,636 205,389 189,336
Restructuring and other, net (3,062 ) 1,560 8,013 29,428
Operating income from continuing operations 510,254 138,248 978,581 361,973
Interest income (348 ) (570 ) (1,010 ) (1,495 )
Interest expense 12,404 14,421 49,712 63,627
Loss on disposition of businesses and assets, net - - - 2,469
Debt extinguishment costs - 32,070 - 32,541
Other expense (income), net 25,107 27,031 23,515 27,689
Income from continuing operations, before income taxes 473,091 65,296 906,364 237,142
Provision for income taxes 92,657 747 178,266 9,389
Income from continuing operations 380,434 64,549 728,098 227,753
Loss on disposition of discontinued operations, before income taxes (76 ) - (76 ) -
Provision for income taxes on discontinued operations and dispositions (3 ) 48 135 195
Loss from discontinued operations and dispositions (73 ) (48 ) (211 ) (195 )
Net income $ 380,361 $ 64,501 $ 727,887 $ 227,558
Diluted earnings per share:
Income from continuing operations $ 3.38 $ 0.58 $ 6.50 $ 2.04
Loss from discontinued operations and dispositions (0.00 ) (0.00 ) (0.00 ) (0.00 )
Net income $ 3.38 $ 0.58 $ 6.49 $ 2.04
Weighted average diluted shares of common stock outstanding 112,537 111,625 112,085 111,501
ABOVE PREPARED IN ACCORDANCE WITH GAAP
Additional Supplemental Information (1) :
(per share, continuing operations)
GAAP EPS from continuing operations $ 3.38 $ 0.58 $ 6.50 $ 2.04
Amortization of intangible assets 0.44 0.39 1.72 1.47
Debt extinguishment costs - 0.29 - 0.29
Purchase accounting adjustments 0.01 0.07 (0.04 ) 0.24
Acquisition and divestiture-related costs 0.02 0.01 0.08 0.06
Change in fair value of financial securities - (0.03 ) (0.00 ) (0.03 )
Acceleration of executive compensation - - - 0.07
Significant litigation matters and settlements 0.03 0.01 0.06 0.02
Significant environmental matters - - 0.05 -
Disposition of businesses and assets, net - - - 0.02
Mark to market on postretirement benefits 0.23 0.28 0.23 0.28
Restructuring and other, net (0.03 ) 0.01 0.07 0.26
Asset impairment 0.07 - 0.07 -
Tax on above items (0.19 ) (0.25 ) (0.57 ) (0.65 )
Impact of tax act - - - 0.02
Significant tax items - - 0.14 -
Adjusted EPS $ 3.96 $ 1.35 $ 8.30 $ 4.10
(1) amounts may not sum due to rounding
PerkinElmer, Inc. and Subsidiaries
REVENUE AND OPERATING INCOME (LOSS)
Three Months Ended Twelve Months Ended
(In thousands, except percentages) January 3, 2021 December 29, 2019 January 3, 2021 December 29, 2019
DAS Reported revenue $ 502,783 $ 496,457 $ 1,715,803 $ 1,746,161
Purchase accounting adjustments 297 - 297 -
Adjusted Revenue 503,080 496,457 1,716,100 1,746,161
Reported operating income from continued operations 72,839 91,368 183,471 238,331
OP% 14.5 % 18.4 % 10.7 % 13.6 %
Amortization of intangible assets 17,479 15,793 76,302 52,898
Purchase accounting adjustments 581 8,377 (10,753 ) 20,857
Acquisition and divestiture-related costs 1,017 375 8,062 1,778
Significant litigation matters and settlements 3,492 569 5,891 2,189
Restructuring and other, net (2,970 ) (469 ) 3,763 21,958
Adjusted operating income 92,438 116,013 266,736 338,011
Adjusted OP% 18.4 % 23.4 % 15.5 % 19.4 %
Diagnostics Reported revenue 851,823 309,039 2,066,942 1,137,512
Purchase accounting adjustments 198 194 786 770
Adjusted Revenue 852,021 309,233 2,067,728 1,138,282
Reported operating income from continued operations 460,496 61,146 874,206 189,330
OP% 54.1 % 19.8 % 42.3 % 16.6 %
Amortization of intangible assets 32,207 27,335 116,250 111,429
Purchase accounting adjustments 930 (369 ) 5,802 5,412
Acquisition and divestiture-related costs 348 332 671 2,210
Significant litigation matters and settlements - 106 1,245 106
Asset impairment 7,937 - 7,937 -
Restructuring and other, net (92 ) 2,029 4,250 7,470
Adjusted operating income 501,826 90,579 1,010,361 315,957
Adjusted OP% 58.9 % 29.3 % 48.9 % 27.8 %
Corporate Reported operating loss (23,081 ) (14,266 ) (79,096 ) (65,688 )
Significant environmental matters - - 5,242 -
Acceleration of executive compensation - - - 7,721
Adjusted operating loss (23,081 ) (14,266 ) (73,854 ) (57,967 )
Continuing Operations Reported revenue $ 1,354,606 $ 805,496 $ 3,782,745 $ 2,883,673
Purchase accounting adjustments 495 194 1,083 770
Adjusted Revenue 1,355,101 805,690 3,783,828 2,884,443
Reported operating income from continued operations 510,254 138,248 978,581 361,973
OP% 37.7 % 17.2 % 25.9 % 12.6 %
Amortization of intangible assets 49,686 43,128 192,552 164,327
Purchase accounting adjustments 1,511 8,008 (4,951 ) 26,269
Acquisition and divestiture-related costs 1,365 707 8,733 3,988
Acceleration of executive compensation - - - 7,721
Significant litigation matters and settlements 3,492 675 7,136 2,295
Significant environmental matters - - 5,242 -
Asset impairment 7,937 - 7,937 -
Restructuring and other, net (3,062 ) 1,560 8,013 29,428
Adjusted operating income $ 571,183 $ 192,326 $ 1,203,243 $ 596,001
Adjusted OP% 42.2 % 23.9 % 31.8 % 20.7 %
REPORTED REVENUE AND REPORTED OPERATING INCOME (LOSS) PREPARED IN ACCORDANCE WITH GAAP
PerkinElmer, Inc. and Subsidiaries
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands) January 3, 2021 December 29, 2019
Current assets:
Cash and cash equivalents $ 402,036 $ 191,877
Accounts receivable, net 1,205,080 725,184
Inventories, net 514,567 356,937
Other current assets 167,208 100,381
Total current assets 2,288,891 1,374,379
Property, plant and equipment:
At cost 818,197 701,580
Accumulated depreciation (449,893 ) (383,357 )
Property, plant and equipment, net 368,304 318,223
Operating lease right-of-use assets 207,236 167,276
Intangible assets, net 1,365,693 1,283,286
Goodwill 3,447,114 3,111,227
Other assets, net 333,048 284,173
Total assets $ 8,010,286 $ 6,538,564
Current liabilities:
Current portion of long-term debt $ 380,948 $ 9,974
Accounts payable 327,325 235,855
Short-term accrued restructuring and other 4,716 11,559
Accrued expenses and other current liabilities 986,998 503,332
Current liabilities of discontinued operations 2,173 2,112
Total current liabilities 1,702,160 762,832
Long-term debt 1,609,701 2,064,041
Long-term liabilities 774,531 751,468
Operating lease liabilities 188,402 146,399
Total liabilities 4,274,794 3,724,740
Total stockholders' equity 3,735,492 2,813,824
Total liabilities and stockholders' equity $ 8,010,286 $ 6,538,564
PREPARED IN ACCORDANCE WITH GAAP
PerkinElmer, Inc. and Subsidiaries
CONSOLIDATED STATEMENTS OF CASH FLOWS
Three Months Ended Twelve Months Ended
January 3, 2021 December 29, 2019 January 3, 2021 December 29, 2019
(In thousands) (In thousands)
Operating activities:
Net income $ 380,361 $ 64,501 $ 727,887 $ 227,558
Loss from discontinued operations and dispositions, net of income taxes 73 48 211 195
Income from continuing operations 380,434 64,549 728,098 227,753
Adjustments to reconcile income from continuing operations to net cash provided by continuing operations:
Stock-based compensation 9,355 6,409 29,126 31,514
Restructuring and other, net (3,062 ) 1,560 8,013 29,428
Depreciation and amortization 63,986 56,908 246,507 214,025
Pension and other postretirement expenses 18,012 26,107 18,012 26,107
Change in fair value of contingent consideration (20 ) (518 ) (8,827 ) 3,881
Amortization of deferred debt financing costs and accretion of discounts 833 1,068 3,391 3,846
Loss on disposition of businesses and assets, net - - 886 2,469
Change in fair value of financial securities (35 ) (3,249 ) (35 ) (3,249 )
Debt extinguishment costs - 32,070 - 32,541
Amortization of acquired inventory revaluation 1,036 8,332 2,793 21,590
Asset impairment 7,937 - 7,937 -
Deferred taxes (32,437 ) (61,353 ) (32,437 ) (61,353 )
Contingencies and non-cash tax matters 4,516 (424 ) 4,516 (424 )
Changes in assets and liabilities which provided (used) cash, excluding effects from companies acquired:
Accounts receivable, net (356,171 ) (78,498 ) (423,866 ) (100,630 )
Inventories (1,579 ) 38,761 (122,513 ) (9,607 )
Accounts payable 46,363 41,394 62,753 7,351
Accrued expenses and other 342,931 82,094 367,823 (61,773 )
Net cash provided by operating activities of continuing operations 482,099 215,210 892,177 363,469
Net cash used in operating activities of discontinued operations - - - -
Net cash provided by operating activities 482,099 215,210 892,177 363,469
Investing activities:
Capital expenditures (20,115 ) (23,249 ) (77,506 ) (76,331 )
Purchases of investments (10,500 ) (1,000 ) (20,059 ) (6,387 )
Purchases of licenses - - - (5,000 )
Proceeds from surrender of life insurance policies 151 - 282 -
Proceeds from disposition of businesses and assets 1,857 - 4,280 550
Payment of acquisitions, net of cash, cash equivalents and restricted cash acquired (407,794 ) (147,785 ) (411,495 ) (400,405 )
Net cash used in investing activities of continuing operations (436,401 ) (172,034 ) (504,498 ) (487,573 )
Net cash provided by investing activities of discontinued operations - - - -
Net cash used in investing activities (436,401 ) (172,034 ) (504,498 ) (487,573 )
Financing Activities:
Payments on borrowings (382,464 ) (273,000 ) (897,674 ) (1,692,489 )
Proceeds from borrowings 457,698 565,000 714,698 1,599,416
Payments of senior debt - (530,276 ) - (530,276 )
Proceeds from sale of senior debt - - - 847,195
Payments of debt financing costs - (1,854 ) - (9,879 )
Settlement of cash flow hedges (2,465 ) 307 (4,554 ) (1,280 )
Net payments on other credit facilities 3,630 (3,911 ) (4,494 ) (14,975 )
Payments for acquisition-related contingent consideration (5,163 ) (1,742 ) (10,363 ) (29,942 )
Proceeds from issuance of common stock under stock plans 10,143 2,169 37,671 19,732
Purchases of common stock (116 ) (112 ) (6,944 ) (6,313 )
Dividends paid (7,831 ) (7,777 ) (31,212 ) (31,059 )
Net cash provided by (used in) financing activities of continuing operations 73,432 (251,196 ) (202,872 ) 150,130
Net cash used in financing activities of discontinued operations - - - -
Net cash provided by (used in) financing activities 73,432 (251,196 ) (202,872 ) 150,130
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 25,081 3,937 25,913 (447 )
Net increase (decrease) in cash, cash equivalents, and restricted cash 144,211 (204,083 ) 210,720 25,579
Cash, cash equivalents, and restricted cash at beginning of period 258,403 395,977 191,894 166,315
Cash, cash equivalents, and restricted cash at end of period $ 402,614 $ 191,894 $ 402,614 $ 191,894
Supplemental disclosure of cash flow information:
Reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total shown in the consolidated statements of cash flows:
Cash and cash equivalents $ 402,036 $ 191,877 $ 402,036 $ 191,877
Restricted cash included in other current assets 578 17 578 17
Total cash, cash equivalents and restricted cash $ 402,614 $ 191,894 $ 402,614 $ 191,894
PREPARED IN ACCORDANCE WITH GAAP
PerkinElmer, Inc. and Subsidiaries
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (1)
(In millions, except per share data and percentages) PKI
Three Months Ended
January 3, 2021 December 29, 2019
Adjusted revenue:
Revenue $ 1,354.6 $ 805.5
Purchase accounting adjustments 0.5 0.2
Adjusted revenue $ 1,355.1 $ 805.7
Adjusted gross margin:
Gross margin $ 827.1 61.1 % $ 398.2 49.4 %
Amortization of intangible assets 16.5 1.2 % 15.8 2.0 %
Purchase accounting adjustments 1.5 0.1 % 8.5 1.1 %
Asset impairment 7.9 0.6 % - 0.0 %
Adjusted gross margin $ 853.0 62.9 % $ 422.5 52.4 %
Adjusted SG&A:
SG&A $ 263.1 19.4 % $ 210.7 26.2 %
Amortization of intangible assets (33.2 ) -2.4 % (27.4 ) -3.4 %
Purchase accounting adjustments 0.0 0.0 % 0.5 0.1 %
Acquisition and divestiture-related costs (1.4 ) -0.1 % (0.7 ) -0.1 %
Significant litigation matters and settlements (3.5 ) -0.3 % (0.7 ) -0.1 %
Adjusted SG&A $ 225.0 16.6 % $ 182.5 22.7 %
Adjusted R&D:
R&D $ 56.8 4.2 % $ 47.6 5.9 %
Adjusted R&D $ 56.8 4.2 % $ 47.6 5.9 %
Adjusted operating income:
Operating income $ 510.3 37.7 % $ 138.2 17.2 %
Amortization of intangible assets 49.7 3.7 % 43.1 5.4 %
Purchase accounting adjustments 1.5 0.1 % 8.0 1.0 %
Acquisition and divestiture-related costs 1.4 0.1 % 0.7 0.1 %
Significant litigation matters and settlements 3.5 0.3 % 0.7 0.1 %
Asset impairment 7.9 0.6 % - 0.0 %
Restructuring and other, net (3.1 ) -0.2 % 1.6 0.2 %
Adjusted operating income $ 571.2 42.2 % $ 192.3 23.9 %
PKI
Three Months Ended
January 3, 2021 December 29, 2019
Adjusted EPS:
GAAP EPS $ 3.38 $ 0.58
Discontinued operations, net of income taxes (0.00 ) (0.00 )
GAAP EPS from continuing operations 3.38 0.58
Amortization of intangible assets 0.44 0.39
Debt extinguishment costs - 0.29
Purchase accounting adjustments 0.01 0.07
Acquisition and divestiture-related costs 0.02 0.01
Change in fair value of financial securities - (0.03 )
Significant litigation matters and settlements 0.03 0.01
Mark to market on postretirement benefits 0.23 0.28
Asset impairment 0.07 -
Restructuring and other, net (0.03 ) 0.01
Tax on above items (0.19 ) (0.25 )
Adjusted EPS $ 3.96 $ 1.35
DAS
Three Months Ended
January 3, 2021 December 29, 2019
Adjusted revenue:
Revenue $ 502.8 $ 496.5
Purchase accounting adjustments 0.3 -
Adjusted revenue $ 503.1 $ 496.5
Adjusted operating income:
Operating income $ 72.8 14.5 % $ 91.4 18.4 %
Amortization of intangible assets 17.5 3.5 % 15.8 3.2 %
Purchase accounting adjustments 0.6 0.1 % 8.4 1.7 %
Acquisition and divestiture-related costs 1.0 0.2 % 0.4 0.1 %
Significant litigation matters and settlements 3.5 0.7 % 0.6 0.1 %
Restructuring and other, net (3.0 ) -0.6 % (0.5 ) -0.1 %
Adjusted operating income $ 92.4 18.4 % $ 116.0 23.4 %
Diagnostics
Three Months Ended
January 3, 2021 December 29, 2019
Adjusted revenue:
Revenue $ 851.8 $ 309.0
Purchase accounting adjustments 0.2 0.2
Adjusted revenue $ 852.0 $ 309.2
Adjusted operating income:
Operating income $ 460.5 54.1 % $ 61.1 19.8 %
Amortization of intangible assets 32.2 3.8 % 27.3 8.8 %
Purchase accounting adjustments 0.9 0.1 % (0.4 ) -0.1 %
Acquisition and divestiture-related costs 0.3 0.0 % 0.3 0.1 %
Significant litigation matters and settlements - 0.0 % 0.1 0.0 %
Asset impairment 7.9 0.9 % - 0.0 %
Restructuring and other, net (0.1 ) 0.0 % 2.0 0.7 %
Adjusted operating income $ 501.8 58.9 % $ 90.6 29.3 %
(1) amounts may not sum due to rounding
PerkinElmer, Inc. and Subsidiaries
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (1)
(In millions, except per share data and percentages) PKI
Twelve Months Ended
January 3, 2021 December 29, 2019
Adjusted revenue:
Revenue $ 3,782.7 $ 2,883.7
Purchase accounting adjustments 1.1 0.8
Adjusted revenue $ 3,783.8 $ 2,884.4
Adjusted gross margin:
Gross margin $ 2,109.9 55.8 % $ 1,396.1 48.4 %
Amortization of intangible assets 65.3 1.7 % 61.4 2.1 %
Purchase accounting adjustments 3.9 0.1 % 22.4 0.8 %
Asset impairment 7.9 0.2 % - 0.0 %
Adjusted gross margin $ 2,186.9 57.8 % $ 1,479.8 51.3 %
Adjusted SG&A:
SG&A $ 917.9 24.3 % $ 815.3 28.3 %
Amortization of intangible assets (127.3 ) -3.4 % (103.0 ) -3.6 %
Purchase accounting adjustments 8.8 0.2 % (3.9 ) -0.1 %
Acquisition and divestiture-related costs (8.7 ) -0.2 % (4.0 ) -0.1 %
Acceleration of executive compensation - 0.0 % (7.7 ) -0.3 %
Significant litigation matters and settlements (7.1 ) -0.2 % (2.3 ) -0.1 %
Significant environmental matters (5.2 ) -0.1 % - 0.0 %
Adjusted SG&A $ 778.3 20.6 % $ 694.5 24.1 %
Adjusted R&D:
R&D $ 205.4 5.4 % $ 189.3 6.6 %
Adjusted R&D $ 205.4 5.4 % $ 189.3 6.6 %
Adjusted operating income:
Operating income $ 978.6 25.9 % $ 362.0 12.6 %
Amortization of intangible assets 192.6 5.1 % 164.3 5.7 %
Purchase accounting adjustments (5.0 ) -0.1 % 26.3 0.9 %
Acquisition and divestiture-related costs 8.7 0.2 % 4.0 0.1 %
Acceleration of executive compensation - 0.0 % 7.7 0.3 %
Significant litigation matters and settlements 7.1 0.2 % 2.3 0.1 %
Significant environmental matters 5.2 0.1 % - 0.0 %
Asset impairment 7.9 0.2 % - 0.0 %
Restructuring and other, net 8.0 0.2 % 29.4 1.0 %
Adjusted operating income $ 1,203.2 31.8 % $ 596.0 20.7 %
PKI
Twelve Months Ended
January 3, 2021 December 29, 2019
Adjusted EPS:
GAAP EPS $ 6.49 $ 2.04
Discontinued operations (0.00 ) (0.00 )
GAAP EPS from continuing operations 6.50 2.04
Amortization of intangible assets 1.72 1.47
Debt extinguishment costs - 0.29
Purchase accounting adjustments (0.04 ) 0.24
Significant litigation matters and settlements 0.06 0.02
Significant environmental matters 0.05 -
Acquisition and divestiture-related costs 0.08 0.06
Change in fair value of financial securities (0.00 ) (0.03 )
Acceleration of executive compensation - 0.07
Loss on disposition of businesses and assets, net - 0.02
Mark to market on postretirement benefits 0.23 0.28
Asset impairment 0.07 -
Restructuring and other, net 0.07 0.26
Tax on above items (0.57 ) (0.65 )
Impact of tax act - 0.02
Significant tax items 0.14 -
Adjusted EPS $ 8.30 $ 4.10
PKI
Three Months Ended Twelve Months Ended
April 4, 2021 January 2, 2022
Adjusted EPS: Projected Projected
GAAP EPS from continuing operations at least $2.52 at least $6.73
Amortization of intangible assets 0.48 2.02
Purchase accounting adjustments 0.03 0.06
Acquisition and divestiture-related costs 0.05 0.05
Restructuring and other, net 0.06 0.21
Tax on above items (0.14 ) (0.57 )
Adjusted EPS at least $3.00 at least $8.50
DAS
Twelve Months Ended
January 3, 2021 December 29, 2019
Adjusted revenue:
Revenue $ 1,715.8 $ 1,746.2
Purchase accounting adjustments 0.3 -
Adjusted revenue $ 1,716.1 $ 1,746.2
Adjusted operating income:
Operating income $ 183.5 10.7 % $ 238.3 13.6 %
Amortization of intangible assets 76.3 4.4 % 52.9 3.0 %
Purchase accounting adjustments (10.8 ) -0.6 % 20.9 1.2 %
Acquisition and divestiture-related costs 8.1 0.5 % 1.8 0.1 %
Significant litigation matters and settlements 5.9 0.3 % 2.2 0.1 %
Restructuring and other, net 3.8 0.2 % 22.0 1.3 %
Adjusted operating income $ 266.7 15.5 % $ 338.0 19.4 %
Diagnostics
Twelve Months Ended
January 3, 2021 December 29, 2019
Adjusted revenue:
Revenue $ 2,066.9 $ 1,137.5
Purchase accounting adjustments 0.8 0.8
Adjusted revenue $ 2,067.7 $ 1,138.3
Adjusted operating income:
Operating income $ 874.2 42.3 % $ 189.3 16.6 %
Amortization of intangible assets 116.3 5.6 % 111.4 9.8 %
Purchase accounting adjustments 5.8 0.3 % 5.4 0.5 %
Acquisition and divestiture-related costs 0.7 0.0 % 2.2 0.2 %
Significant litigation matters and settlements 1.2 0.1 % 0.1 0.0 %
Asset impairment 7.9 0.4 % - 0.0 %
Restructuring and other, net 4.3 0.2 % 7.5 0.7 %
Adjusted operating income $ 1,010.4 48.9 % $ 316.0 27.8 %
(1) amounts may not sum due to rounding
PerkinElmer, Inc. and Subsidiaries
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (1)
PKI
Three Months Ended
January 3, 2021
Organic revenue growth:
Reported revenue growth 68%
Less: effect of foreign exchange rates 3%
Less: effect of acquisitions including purchase accounting adjustments and impact of divested businesses 0%
Organic revenue growth 65%
DAS
Three Months Ended
January 3, 2021
Organic revenue growth:
Reported revenue growth 1%
Less: effect of foreign exchange rates 3%
Less: effect of acquisitions including purchase accounting adjustments and impact of divested businesses 0%
Organic revenue growth -2%
Diagnostics
Three Months Ended
January 3, 2021
Organic revenue growth:
Reported revenue growth 176%
Less: effect of foreign exchange rates 3%
Less: effect of acquisitions including purchase accounting adjustments and impact of divested businesses 0%
Organic revenue growth 172%
(1) amounts may not sum due to rounding
PerkinElmer, Inc. and Subsidiaries
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (1)
DAS
Twelve Months Ended
January 3, 2021
Organic revenue growth:
Reported revenue growth -2%
Less: effect of foreign exchange rates 0%
Less: effect of acquisitions including purchase accounting adjustments and impact of divested businesses 2%
Organic revenue growth -4%
Diagnostics
Twelve Months Ended
January 3, 2021
Organic revenue growth:
Reported revenue growth 82%
Less: effect of foreign exchange rates 0%
Less: effect of acquisitions including purchase accounting adjustments and impact of divested businesses 0%
Organic revenue growth 81%
(1) amounts may not sum due to rounding
Explanation of Non-GAAP Financial Measures
We report our financial results in accordance with GAAP. However, management believes that, in order to more fully understand our short-term and long-term financial and operational trends, investors may wish to consider the impact of certain
non-cash, non-recurring or other items, which result from facts and circumstances that vary in frequency and impact on continuing operations. Accordingly, we present non-GAAP financial measures as a supplement to the financial measures we
present in accordance with GAAP. These non-GAAP financial measures provide management with additional means to understand and evaluate the operating results and trends in our ongoing business by adjusting for certain non-cash expenses and other
items that management believes might otherwise make comparisons of our ongoing business with prior periods more difficult, obscure trends in ongoing operations, or reduce management's ability to make useful forecasts. Management believes these
non-GAAP financial measures provide additional means of evaluating period-over-period operating performance. In addition, management understands that some investors and financial analysts find this information helpful in analyzing our financial
and operational performance and comparing this performance to our peers and competitors.
We use the term "adjusted revenue" to refer to GAAP revenue, including purchase accounting adjustments for revenue from contracts acquired in acquisitions that will not be fully recognized due to accounting rules. We use the related term
"adjusted revenue growth" to refer to the measure of comparing current period adjusted revenue with the corresponding period of the prior year.
We use the term "organic revenue" to refer to GAAP revenue, excluding the effect of foreign currency changes and including acquisitions growth from the comparable prior period, and including purchase accounting adjustments for revenue from
contracts acquired in acquisitions that will not be fully recognized due to accounting rules. We also exclude the impact of sales from divested businesses by deducting the effects of divested business revenue from the current and prior periods.
We use the related term "organic revenue growth" to refer to the measure of comparing current period organic revenue with the corresponding period of the prior year.
We use the term "adjusted gross margin" to refer to GAAP gross margin, excluding amortization of intangible assets and inventory fair value adjustments related to business acquisitions, and including purchase accounting adjustments for
revenue from contracts acquired in acquisitions that will not be fully recognized due to business combination accounting rules. We use the related term "adjusted gross margin percentage" to refer to adjusted gross margin as a percentage of
We use the term "adjusted SG&A expense" to refer to GAAP SG&A expense, excluding amortization of intangible assets, purchase accounting adjustments, acquisition and divestiture-related expenses, acceleration of executive compensation,
significant litigation matters and settlements, and significant environmental charges. We use the related term "adjusted SG&A percentage" to refer to adjusted SG&A expense as a percentage of adjusted revenue.
We use the term "adjusted R&D expense" to refer to GAAP R&D expense, excluding amortization of intangible assets and purchase accounting adjustments. We use the related term "adjusted R&D percentage" to refer to adjusted R&D
expense as a percentage of adjusted revenue.
We use the term "adjusted net interest and other expense" to refer to GAAP net interest and other expense, excluding adjustments for mark-to-market accounting on post-retirement benefits, changes in the value of financial securities and debt
extinguishment costs.
We use the term "adjusted operating income," to refer to GAAP operating income, including revenue from contracts acquired in acquisitions that will not be fully recognized due to accounting rules, and excluding amortization of intangible
assets, other purchase accounting adjustments, acquisition and divestiture-related expenses, acceleration of executive compensation, significant litigation matters and settlements, significant environmental charges, and restructuring and other
charges. We use the related terms "adjusted operating profit percentage," "adjusted operating profit margin," or "adjusted operating margin" to refer to adjusted operating income as a percentage of adjusted revenue.
We use the term "adjusted earnings per share," or "adjusted EPS," to refer to GAAP earnings per share, including revenue from contracts acquired in acquisitions that will not be fully recognized due to accounting rules, and excluding
discontinued operations, amortization of intangible assets, debt extinguishment costs, other purchase accounting adjustments, acquisition and divestiture-related expenses, acceleration of executive compensation, significant litigation matters
and settlements, significant environmental charges, changes in the value of financial securities, disposition of businesses and assets, net, asset impairments and restructuring and other charges. We also exclude adjustments for mark-to-market
accounting on post-retirement benefits, therefore only our projected costs have been used to calculate this non-GAAP measure. We also adjust for any tax impact related to the above items and exclude the impact of significant tax events.
Management includes or excludes the effect of each of the items identified below in the applicable non-GAAP financial measure referenced above for the reasons set forth below with respect to that item:
Amortization of intangible assets- purchased intangible assets are amortized over their estimated useful lives and generally cannot be changed or influenced by management after the acquisition.
Accordingly, this item is not considered by management in making operating decisions. Management does not believe such charges accurately reflect the performance of our ongoing operations for the period in which such charges are incurred.
Debt extinguishment costs-we incur costs and income related to the extinguishment of debt; including make-whole payments to debt holders, accelerated amortization of debt fees and discounts, and expense
or income from hedges to lock in make whole payments. We exclude the impact of these items from our non-GAAP measures because we believe they do not reflect the performance of our ongoing operations.
Revenue from contracts acquired in acquisitions that will not be fully recognized due to accounting rules-accounting rules require us to account for the fair value of revenue from contracts assumed in
connection with our acquisitions. As a result, our GAAP results reflect the fair value of those revenues, which is not the same as the revenue that otherwise would have been recorded by the acquired entity. We include such revenue in our
Last updated: Feb 2, 2021